Form 4: HealthEquity Director Gayle Furgurson Wellborn Executes Stock Option and Sells Shares

Sentiment:

SEC Form 4


Director Gayle Furgurson Wellborn exercised stock options and sold shares of HealthEquity, Inc. on July 9, 2024.

Summary

  • On July 9, 2024, Gayle Furgurson Wellborn, a director of HealthEquity, Inc., exercised stock options to acquire 5,297 shares of common stock at a price of $47.21 per share.
  • Simultaneously, Wellborn sold 5,297 shares of common stock at a price of $81.34 per share.
  • Following these transactions, Wellborn directly owns 17,730 shares of HealthEquity common stock.
  • Wellborn also holds 2,439 stock options with an exercise price of $47.21 and 4,339 stock options with an exercise price of $50.41.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the trading activities of company directors.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.

Key Dates

DateDescription
06/26/2023Power of Attorney given by Ms. Wellborn was previously filed with the U.S. Securities and Exchange Commission.
07/09/2024Earliest transaction date: Exercise of stock options and sale of common stock.
07/10/2024Date of signature for the Form 4 filing.
08/01/2027Expiration date for some stock options.
02/01/2028Expiration date for some stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.